El colesterol HDL: ¿un nuevo objetivo terapéutico en el manejo de las dislipidemias y la ateroesclerosis?

Autor: Laris E, María del Rosario, Arteaga L, Antonio, Cuevas M, Ada, Rigotti R, Attilio

Publikováno v: REVISTA MEDICA DE CHILE
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Revista médica de Chile, Volume: 133, Issue: 7, Pages: 823-832, Published: JUL 2005

Low plasma HDL cholesterol levels are an independent risk factor for atherosclerotic cardiovascular disease. During the past years, the study of HDL has been stimulated by the discovery of novel genes and proteins, which have provided new insights in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6404942b8de16ca359cfac3713dc4919